Skip to main content
Log in

Olanzapine/paliperidone

Neuroleptic malignant syndrome following olanzapine withdrawal: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Garcia-Atienza EM, et al. Olanzapine as a cause of neuroleptic malignant syndrome, bibliographic review following a clinical case. [Review]. Actas Espanolas de Psiquiatria 46: 112-114, No. 3, May 2018. Available from: URL: https://www.ncbi.nlm.nih.gov/pubmed/29892970 [Spanish; summarised from a translation] - Spain

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Olanzapine/paliperidone. Reactions Weekly 1761, 285 (2019). https://doi.org/10.1007/s40278-019-64657-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-64657-0

Navigation